Quantessence Capital’s GE HealthCare GEHC Stock Holding History

Quantessence Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,825	Closed	-$309K	–	283
2025 Q1	$309K	Buy	+3,825	New	+$329K	0.08%	235

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantessence Capital's GEHC Position: Q2 2025 in Review

Quantessence Capital sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 3,825 shares — an estimated $309K sold.

Quantessence Capital first reported a position in GEHC in Q1 2025 and held it in 1 quarter. The position peaked at $309K in Q1 2025. 1,311 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

Quantessence Capital reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 3,825 GE HealthCare shares in Q2 2025, an estimated $309K.
Quantessence Capital first reported a position in GE HealthCare in Q1 2025 and held it in 1 quarter.
Quantessence Capital's GE HealthCare position peaked at $309K in Q1 2025.
1,311 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.